CytoDyn raises $5 million in private share placement
CYDY•CytoDyn raised $5 million from an existing investor at $0.24 per common share, with no warrants. It plans to use the proceeds to support leronlimab development in colorectal cancer, earlier treatment settings and other solid tumors.
1. Private placement
CytoDyn raised $5 million through a private investment from an existing investor. The common shares were purchased for $0.24 each, with no accompanying warrants. Proceeds will support leronlimab development in colorectal cancer, earlier treatment settings and other solid tumors.
